Yui Tomo

Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysis

N. Watanabe, R. Okubo, T. Sumiyoshi, 2022, Frontiers in Psychology.

Implementation of a shared decision-making training program for clinicians based on the major depressive disorder guidelines in Japan: A multi-center cluster randomized trial

Y. Takaesu, Koichiro Watanabe, T. Tsuboi, 2022, Frontiers in Psychiatry.

Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study

Y. Kimura, Kei Yamada, U. Tateishi, 2022, Annals of Nuclear Medicine.

Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial

K. Ikeda, Yasukazu Ogai, K. Maruo, 2022, Neuropsychopharmacology reports.

Single-trial Neuromagnetic Analysis Reveals Somatosensory Dysfunction in Chronic Minamata Disease

S. Tobimatsu, S. Taulu, Yoko Miura, 2023, NeuroImage: Clinical.

Perilla Oil and Bifidobacterium for Alleviating Fear of Cancer Recurrence in Breast Cancer Survivors: Study Protocol for a Three-Arm Phase II Randomized Controlled Study (POB Study)

T. Kinoshita, Y. Matsuoka, R. Okubo, 2021, Methods and protocols.

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients

Y. Maegaki, T. Matsumura, H. Tachimori, 2023, Annals of clinical and translational neurology.